Effects of 2 Mu-opiates on Gastrointestinal Transit Completed Phase 4 Trials for Tapentadol (DB06204)

IndicationStatusPhase
DBCOND0055228 (Effects of 2 Mu-opiates on Gastrointestinal Transit)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01500317Comparison of the Effects of Tapentadol and Oxycodone on Gastrointestinal and Colonic Transit in HumansSupportive Care